Monsanto, Roberto .
HRN: 24-13-58 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2023
MUPIROCIN 2%, 15G (TUBE)
11/26/2023
12/02/2023
TOPICAL
Thinly
BID
Multiple Soft Tissue Injury
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes